Moderna Booster Found To Be Effective Against Rising New COVID-19 Strains

The fight against COVID-19 continues with most parts of the world getting vaccinated. But the problem right now is that new strains of the virus are coming out. Hence, it raises the question of whether the single or two-dose shots of available vaccines are effective against the new strains coming out. It appears Moderna booster has been proven efficient against it.

The company announced on Wednesday that new data shows that the third shot of Moderna has proven to be effective against the new COVID-19 strains according to company CEO Stéphane Bancel.

“As we seek to defeat the ongoing pandemic, we remain committed to being proactive as the virus evolves,” she stated. “We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against these newly detected variants.”

The new strain first appeared over in Brazil and South Africa. Per human trials, Moderna’s third vaccine has increased the immune system of the individuals. It neutralizes antibodies against the so-called B.1.351 South Africa variant per a company statement.

Concern grows on how well the current vaccines that companies can hold up against the new strains of COVID-19. Except for Moderna, some fear that even with the usual doses of other COVID-19 vaccines, the possibility of getting reinfected may be possible.

Aware of such, Moderna is doing its part to make sure that they do not let their guards down with continuous monitoring to make sure that people are kept well-protected on the new strains, something that could render current vaccines useless.

“We will continue to make as many updates to our COVID-19 vaccine as necessary to control the pandemic,” Bancel said.

Aside from Moderna, it remains to be seen if other companies who have offered their versions of COVID-19 vaccines can provide some encouragement or an added dose against the coronavirus. Countries like India and Brazil have seen a surge in COVID-19 numbers, raising questions on whether getting the available vaccines right now would be enough to keep anyone protected.